Abstract: An acoustic liner for a turbine engine, the acoustic liner includes a support layer that includes a set of partitioned cavities with open faces, a perforated sheet that includes a set of perforations with corresponding inlets, the perforated sheet supported by the support layer such that perforations are in overlying relationship with the open faces to form paired perforations and cavities that define acoustic resonator cells, and a coating applied to the perforated sheet.

Abstract: An acoustic liner and a method of attenuating noise are provided. The acoustic liner includes a face sheet, a back sheet spaced from the face sheet, and a core layer extending between the face sheet and the back sheet. The core layer includes a plurality of resonant cells, each resonant cell including at least one cell wall coupled to the back sheet along a cell wall base edge. The at least one cell wall extends from the back sheet at an angle toward the face sheet. The at least one cell wall further coupled to the face sheet along a cell wall top edge. The resonant cell is formed in a predetermined shape and contains a volume in a space defined by the at least one cell wall, the back sheet, and the face sheet. The cell wall base edge length is greater than the cell wall top edge length.

Abstract: An acoustic liner and a method of attenuating noise are provided. The acoustic liner includes a face sheet, a back sheet spaced from the face sheet, and a core layer extending between the face sheet and the back sheet. The core layer includes a plurality of resonant cells, each resonant cell including at least one cell wall coupled to the back sheet along a cell wall base edge. The at least one cell wall extends from the back sheet at an angle toward the face sheet. The at least one cell wall further coupled to the face sheet along a cell wall top edge. The resonant cell is formed in a predetermined shape and contains a volume in a space defined by the at least one cell wall, the back sheet, and the face sheet. The cell wall base edge length is greater than the cell wall top edge length.

Abstract: The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.

Abstract: A single degree of freedom (SDOF) acoustic liner includes a porous face sheet, a substantially imperforate back sheet generally parallel to and opposing said porous face sheet and defining a thickness therebetween, and an acoustic core layer of contiguous adjacent resonant cavities disposed between the porous face sheet and the imperforate back sheet. The acoustic core layer includes a first resonant cell having a first internal volume therein and a second resonant cell having a second internal volume therein different than the first internal volume. A cell partition wall extends between the porous face sheet and the imperforate back sheet, and separates and seals the first resonant cell from the second resonant cell. In a thickness direction, and perpendicular to a plane generally parallel with the porous face sheet and the substantially imperforate back sheet, the first internal volume overlaps the second internal volume over the cell partition wall.

Abstract: An acoustic liner and a method of attenuating noise are provided. The acoustic liner includes a face sheet, a back sheet spaced from the face sheet, and a core layer extending between the face sheet and the back sheet. The core layer includes a plurality of resonant cells, each resonant cell including at least one cell wall coupled to the back sheet along a cell wall base edge. The at least one cell wall extends from the back sheet at an angle toward the face sheet. The at least one cell wall further coupled to the face sheet along a cell wall top edge. The resonant cell is formed in a predetermined shape and contains a volume in a space defined by the at least one cell wall, the back sheet, and the face sheet. The cell wall base edge length is greater than the cell wall top edge length.

Abstract: An acoustic liner (20) with perforation (30) and method of constructing (100) an acoustic liner including forming perforations in the facing sheet by grit blasting (104) the facing sheet and mounting (106) the facing sheet to one side of a support layer having a set of partitioned cavities wherein the facing sheet closes an open face of the cavities except for the perforations to form a set of acoustic resonator cells.

Abstract: The invention relates to a modified VWF molecule for use in the treatment of a blood coagulation disorder.

Abstract: The invention relates to a compound, preferably an antibody, capable of binding to the receptor protein CLEC10A for use in the treatment of a blood coagulation disorder.

Abstract: An acoustic liner for a turbine engine, the acoustic liner includes a support layer that includes a set of partitioned cavities with open faces, a perforated sheet that includes a set of perforations with corresponding inlets, the perforated sheet supported by the support layer such that perforations are in overlying relationship with the open faces to form paired perforations and cavities that define acoustic resonator cells, and a coating applied to the perforated sheet.

Abstract: An acoustic liner for a turbine engine, the acoustic liner includes a support layer that includes a set of partitioned cavities with open faces, a facing sheet operably coupled to the support layer such that the facing sheet overlies and closes the open faces, a set of perforations located in the facing sheet and in fluid communication with a corresponding one of the cavities to form a set of acoustic resonators, and at least a subset of the perforations have an axially-oriented, relative to the axial flow path, inlet.

Abstract: The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.

Abstract: The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.

Abstract: A single degree of freedom (SDOF) acoustic liner includes a porous face sheet, a substantially imperforate back sheet generally parallel to and opposing said porous face sheet and defining a thickness therebetween, and an acoustic core layer of contiguous adjacent resonant cavities disposed between the porous face sheet and the imperforate back sheet. The acoustic core layer includes a first resonant cell having a first internal volume therein and a second resonant cell having a second internal volume therein different than the first internal volume. A cell partition wall extends between the porous face sheet and the imperforate back sheet, and separates and seals the first resonant cell from the second resonant cell. In a thickness direction, and perpendicular to a plane generally parallel with the porous face sheet and the substantially imperforate back sheet, the first internal volume overlaps the second internal volume over the cell partition wall.

Abstract: Disclosed are methods, apparatus, systems, and computer readable storage media for interacting with one or more data objects in an online social network. A user interface includes a publisher with a custom action. The custom action is defined in accordance with custom action instructions provided by a first entity via an application programming interface (API). Such custom action instructions may declaratively or programmatically define the data object, the interaction to be performed with the data object, and other attributes associated with the custom action. A user may request to interact with the data object via selection of the custom action by a second entity. Information may be submitted through the publisher to interact with the data object to update a database system associated with the data object. A feed item may be presented for inclusion in the information feed based on the update.

Abstract: The invention provides a computer implemented method for constructing a patient-specific evidence-informed case rate (ECR) for an episode of medical care spanning a defined period of time for a particular payer-provider-patient triad to create a patient-specific, severity adjusted prospective budget for the patient. ECR Analytics is a tool that constructs episodes of care using administrative claims data, both medical and pharmacy. It calculates the cost of care of patient-specific episodes by assigning relevant services to each episode and further distinguishing those services as typical or routine versus those associated with a complication. The episodes calculated within ECR Analytics can be attributed to specific providers, risk adjusted for performance measurement, and can also be used to construct prospective budgets for payment purposes, such as episode of care payment or reference pricing.

Abstract: Disclosed are methods, apparatus, systems, and computer readable storage media for interacting with one or more data objects in an online social network. A user interface includes a publisher with a custom action. The custom action is defined in accordance with custom action instructions provided by a first entity via an application programming interface (API). Such custom action instructions may declaratively or programmatically define the data object, the interaction to be performed with the data object, and other attributes associated with the custom action. A user may request to interact with the data object via selection of the custom action by a second entity. Information may be submitted through the publisher to interact with the data object to update a database system associated with the data object. A feed item may be presented for inclusion in the information feed based on the update.

Abstract: An internal-combustion engine achieves much higher thermodynamic cycle efficiency than it is possible to achieve in other engines of the same type. It achieves this by operating with a much higher expansion ratio, without an increase in effective compression ratio. The engine geometric compression ratio is considerably larger than it is in conventional engines of the same type. It operates unthrottled most of the time, and the control of the volume of the intake air retained in the cylinder is performed by varying the timing of the intake valve closure. Ignition timing is after the top-dead-center most of the time. Suitable coordination of ignition timing control with intake valve timing control insures that the peak combustion pressure and temperature remain within acceptable limits.

Abstract: The instant invention provides a method to reduce adverse events caused by a pharmaceutical preparation derived from a plasma fraction said plasma fraction comprising antithrombin III wherein the method comprises contacting the plasma fraction with heparin or a heparin-like substance thereby reducing the activity of at least one activated serine protease per ml of the plasma fraction.

Abstract: The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.